ARTICLE | Financial News

Amicus planning $75M follow-on

November 18, 2014 3:24 AM UTC

Amicus Therapeutics Inc. (NASDAQ:FOLD) said it plans to raise $75 million in a follow-on underwritten by JPMorgan; Cowen; Leerink; and Janney Montgomery Scott.

The company is planning to commercialize globally its Amigal migalastat to treat Fabry's disease. It intends to meet with EU regulators by year end and with FDA in early 2015 to discuss a regulatory path for the compound. ...